Reunion Neuroscience to Participate in the Cantor Neurology & Psychiatry Conference
03 oct. 2022 07h30 HE
|
Reunion Neuroscience Inc.
TORONTO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, Nasdaq: REUN) ("Reunion"), or (“the Company”), a global leader in the discovery and development of innovative...
Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder Meeting
29 sept. 2022 17h20 HE
|
Reunion Neuroscience Inc.
TORONTO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) ("Reunion" or the “Company”) today announced the results of the votes held at its September 29, 2022...
Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer
28 sept. 2022 07h30 HE
|
Reunion Neuroscience Inc.
TORONTO, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) ("Reunion" or the “Company”), a leader in novel psychedelic drug development committed to innovating...
Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences
08 sept. 2022 08h00 HE
|
Reunion Neuroscience Inc.
TORONTO, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, Nasdaq: REUN) ("Reunion"), or (“the Company”), a global leader in the discovery and development of innovative...
Reunion Neuroscience Inc. Announces 2022 Annual General Meeting of Shareholders
31 août 2022 07h30 HE
|
Reunion Neuroscience Inc.
TORONTO, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, Nasdaq: REUN) ("Reunion"), or (“the Company”), a global leader in the discovery and development of innovative of...
Reunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange on August 17, 2022
16 août 2022 12h46 HE
|
Reunion Neuroscience Inc.
TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (formerly, Field Trip Health Ltd., the "Company" or “Reunion”), a global leader in the discovery and development of innovative of...
Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal First Quarter 2023 Financial Results, Completed Corporate Reorganization on August 11, 2022
15 août 2022 17h10 HE
|
Reunion Neuroscience Inc.
Completed corporate reorganization, separating the Field Trip Discovery and Field Trip Health divisions into two separate companies.Field Trip Discovery renamed Reunion Neuroscience Inc. (“Reunion” or...
Field Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement Financing
11 août 2022 16h28 HE
|
Reunion Neuroscience Inc.; Field Trip Health & Wellness Ltd.
- Field Trip Health Ltd. has been renamed "Reunion Neuroscience Inc." and remains listed on the NASDAQ Stock Market and Toronto Stock Exchange under the ticker symbol "FTRP" with such ticker symbol...
Field Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 16, 2022, at 8:30 AM ET
08 août 2022 08h00 HE
|
Field Trip Health, Ltd.
TORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, Nasdaq: FTRP) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic therapies,...
Field Trip Health Ltd. Receives Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness Ltd. on the TSX Venture Exchange
04 août 2022 18h29 HE
|
Field Trip Health, Ltd.
– Field Trip Health & Wellness Ltd. to list on the TSX Venture Exchange, with first day of trading expected to occur on or about August 17, 2022. – Field Trip Discovery to be renamed Reunion...